References
- Ho M. Cytomegalovirus: biology and infection. New York: Plenum. 1982
- Krech U, Jung M, Jung F. Cytomegalovirus infections of man. Basel, Switzerland: S Karger, 1971
- Weller TH. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N Engl J Med 1971: 285(Jul): 267–74
- Jordan MC, Jordan GW, Stevens JG, et al. Latent herpesviruses of humans. Ann Intern Med 1984: 100(6): 866–80
- Hanshaw JB. Congenital cytomegalovirus infection: a fifteen-year perspective. J Infect Dis 1971: 123(5): 555–61
- Pass RF, stagno S, Myers GJ, et al. Outcome of symptomatic congenital cytomegalovirus Infection: re-suits of long-term longitudinal follow-up. Pediatrics 1980: 66(5): 758–62
- Kumar ML, Nankervis GA, Gold E. Inapparent congenital cytomegalovirus infection: a follow-up study. N Engl J Med 1973: 288(26): 1370–2
- Reynolds DW, Stagno S, Stubbs KG, et al. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels: causal relation with auditory and mental deficiency. N Engl J Med 1974: 290(6): 291–6
- Hanshaw JB, Scheiner AP, Moxley AW, et al. School failure and deafness after ‘silent’ congenital cytomegalovirus infection. N Engl J Med 1976: 295(9): 468–70
- Stagno S, Pass RF, Dworsky ME, et al. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982: 25(3): 563–76
- Stagno S, Reynolds DW, Pass RF, et al. Breast milk and the risk of cytomegalovirus infection. N Engl J Med 1980: 302(19): 1073–6
- Pass RF. Hutto SC. Reynolds DW. et al. Increased frequency of cytomegalovirus infection in children in group day care. Pediatrics 1984: 74(1): 121–6
- Klemola E, Von Essen R, Henle G, et al. Infectious mononucleosis-like disease with negative heterophil agglutination test: clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis 1970: 121(6): 608–14
- Yeager AS, Grumet FC, Hafleigh EB, et al. Prevention of transfusion-acquired cytomegalovirus Infections In newborn Infants. J Pediatr 1981: 98(2): 281–7
- Dworsky ME, Welch K, Cassady G, et al. Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med 1983: 309(16): 950–3
- Exposure of women to cytomegalovirus infections in medical and educational facilities. Calif Morbid Suppl 1983 (Feb 25): 3
- Young AB, Rdd D, Grist NR. Is cytomegalovirus a serious hazard to female hospital staff? Lancet 1983: 1: 975–6
- Elek SD, Stern H. Development of a vaccine against mental retardation caused by cytomegalovirus infection In utero. Lancet 1974: 1 (845): 1–5
- Plotkin S A, Farquhar J, Horberger E. Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J Infect Dis 1976: 134(5): 470–5
- Balfour HH Jr, Bean B, Mitchell CD, et al. Acyclovir in immunocompromised patients with cytomegalovirus disease: a controlled trial in one institution. Am J Med 1982: 73(1A): 241–8
- Condie RM, O'Reilly RJ. Prevention of cytomegalovirus infection by prophylaxis with an Intravenous, hyperimmune. native, unmodified cytomegalovirus globulin: randomized trial in bone marrow transplant recipients. Am J Med 1984: 76(3A): 134–41
- Cheeseman SH, Rubin RH, Stewart JA, et al. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation: effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med 1979: 300(24): 1345–9
- Thomas IT, Soothill JF, Hawkins GT, et al. Transfer-factor treatment in congenital cytomegalovirus Infection. Lancet 1977: 2(8047): 1056–7